Eli Lilly beats out Bristol-Myers for ImClone
Ending a bidding war, the US pharmaceutical concern Eli Lilly intends to take over the US biotech firm ImClone for 6.5 billion dollar, the two companies said Monday in new York.

ImClone shareholders must approve the offer.

Eli Lilly beat out its US rival Bristol-Myers Squibb, which had raised its offer to 5.4 billion dollars. Bristol-Myers Squibb already owns 17 per cent of ImClone and works closely with the company.


Vote this article

© 2007 - 2008 - eNews 2.0 All Rights Reserved
 


  Send article by e-mail Print article AddThis Social Bookmark Button
 
 
 
Childhood Infections Need to be Better TrackedChildhood Infections Need to be Better Tracked
The federal officials have asked doctors and state health agencies to be more careful when they diagnose children because many of the kids aged under 5 can now be...

Childhood Infections Need to be Better Tracked
 

dotclear
dotclear
 
 
 
Currency USD EUR GBP YEN
USD ------ 0.787 0.671 93.458
EUR 1.271 ------ 0.853 118.822
GBP 1.491 1.173 ------ 139.364
YEN 0.011 0.008 0.007 ------
 
 
 
 
eNews 2.0: Contact Us | Advertise With Us | RSS Feed | All News
eNews 2.0 Corporate: Copyright | Disclaimer | Privacy | About Us | Careers
Copyright © 2007 - 2008 - eNews 2.0 All Rights Reserved. All rights reserved.